As of October 2024, Shanghai RAAS Blood Products has a market cap of $6.22B. This makes Shanghai RAAS Blood Products the world's 2354th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.47B | -13.88% |
2023 | $7.51B | 26.18% |
2022 | $5.95B | -7.04% |
2021 | $6.40B | -7.84% |
2020 | $6.95B | -0.27% |
2019 | $6.96B | -7.37% |
2018 | $7.52B | -59.65% |
2017 | $18.63B | -14.03% |
2016 | $21.67B | 4.51% |
2015 | $20.74B | 76.32% |
2014 | $11.76B | 89.94% |
2013 | $6.19B | 248.75% |
2012 | $1.78B | 2.41% |
2011 | $1.73B | -30.89% |
2010 | $2.51B | 58.81% |
2009 | $1.58B | 47.03% |
2008 | $1.07B | - |